Azenta, Inc. (AZTA) Stock Score, Valuation & Financial Research
Azenta, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 31/100.
Quick answer for AZTA
Azenta, Inc. currently has a Wall Street Score of 31/100. The stored market price is $30.85. Its financial score is 41/100. Its valuation score is 0/100. The latest WSS change is +0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Azenta, Inc. does
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrate
AZTA financial snapshot
- Wall Street Score:
- 31/100
- Current price:
- $30.85
- Market capitalization:
- $1.42B
- Revenue:
- $613.8M
- Net income:
- $-122.9M
- Free cash flow:
- $38.3M
- Cash:
- $189.7M
- Total debt:
- $54.0M
- EPS:
- -2.75
- Financial score:
- 41/100
- Valuation score:
- 0/100
- Revenue score:
- 8/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $38.3M, showing positive cash generation.
- The balance sheet shows $189.7M of cash versus $54.0M of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +0.1 points: AZTA increased 0.1 points because overall fundamentals improved.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 41/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-09.
How to research AZTA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.